Fund shareholders of CytoSorbents Corp
ISIN US23283X2062 · United States · LEI 549300VI8WO8GK5QK793
- Fund shareholders
- 14
- Of which ETFs
- 2 12 other funds
- Value held
- 2M $
- Share of capital
- 5.1 % of 62.8M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,274,363 | 721.7K $ | 2.03 % | as of Mar 31, 2026 ↗ | |
| Neuberger Intrinsic Value Fund NEUBERGER BERMAN EQUITY FUNDS | 647,006 | 486.9K $ | 0.04 % | 1.03 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 540,389 | 306K $ | 0.00 % | 0.86 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 295,933 | 222.7K $ | 0.00 % | 0.47 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 145,480 | 82.4K $ | 0.01 % | 0.23 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 94,319 | 71K $ | 0.00 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 74,873 | 56.3K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 35,641 | 20.2K $ | 0.06 % | as of Mar 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 32,102 | 24.2K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 29,596 | 16.8K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 22,884 | 17.2K $ | 0.00 % | 0.04 % | as of Feb 28, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 11,258 | 6.4K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Column Small Cap Select Fund Trust for Professional Managers | 6,741 | 5.1K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Column Small Cap Fund Trust for Professional Managers | 2,079 | 1.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Neuberger Intrinsic Value Fund NEUBERGER BERMAN EQUITY FUNDS | 0.04 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Column Small Cap Fund Trust for Professional Managers | 0.00 % | as of Feb 28, 2026 ↗ |
| Column Small Cap Select Fund Trust for Professional Managers | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 14 | 0 | 3,212,664 | -0.0 % |
| 2026Q1 | 14 | +2 | 3,213,627 | +0.1 % |
| 2025Q4 | 12 | -2 | 3,208,830 | -6.6 % |
| 2025Q3 | 14 | 0 | 3,436,977 | -1.7 % |
| 2025Q2 | 14 | 0 | 3,498,130 | -5.5 % |
| 2025Q1 | 14 | 0 | 3,700,884 | -6.5 % |
| 2024Q4 | 14 | -3 | 3,956,593 | -9.6 % |
| 2024Q3 | 17 | -1 | 4,375,255 | -10.0 % |
| 2024Q2 | 18 | -2 | 4,862,957 | +4.5 % |
| 2024Q1 | 20 | -3 | 4,655,109 | +17.0 % |
| 2023Q4 | 23 | 3,979,557 |
Institutional managers
47 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| AVENIR CORP | 5,215,776 | 3M $ | as of Mar 31, 2026 |
| Skylands Capital, LLC | 1,707,498 | 967K $ | as of Mar 31, 2026 |
| NEUBERGER BERMAN GROUP LLC | 1,683,007 | 950.8K $ | as of Mar 31, 2026 |
| CM Management, LLC | 1,476,500 | 836.1K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 782,992 | 443.4K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 707,262 | 400.6K $ | as of Mar 31, 2026 |
| Sargent Investment Group, LLC | 549,900 | 311.4K $ | as of Mar 31, 2026 |
| Pathstone Holdings, LLC | 499,955 | 283.1K $ | as of Mar 31, 2026 |
| CIBC Bancorp USA Inc. | 172,649 | 97.8K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 159,293 | 90.2K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 130,419 | 74.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 115,200 | 65.2K $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 107,751 | 61K $ | as of Mar 31, 2026 |
| NWF Advisory Services Inc. | 104,139 | 59K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 100,720 | 57K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 100,169 | 56.7K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 92,540 | 52.4K $ | as of Mar 31, 2026 |
| Key Client Fiduciary Advisors, LLC | 78,457 | 44.4K $ | as of Mar 31, 2026 |
| Waverly Advisors, LLC | 55,556 | 31.5K $ | as of Mar 31, 2026 |
| STIFEL FINANCIAL CORP | 48,000 | 27.2K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 43,947 | 24.9K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 39,123 | 22.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 35,570 | 20.1K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 29,945 | 17K $ | as of Mar 31, 2026 |
| Kestra Advisory Services, LLC | 28,200 | 16K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of CytoSorbents Corp". https://titelia.com/en/stocks/cytosorbents-corp-US23283X2062